Shares of Novo Nordisk A/S were getting hit hard Monday, after the maker of Ozempic and Wegovy, the diabetes and obesity treatments, revealed data showing that its new weight-loss drug candidate ...

But who led the charge on the verbal KO spree? Brendan Schaub. He cranked it up to 11. During an episode of Thiccc Boy podcast the former UFC heavyweight, podcaster, and comedian didn’t just ...

A fast-growing body of research signals potential health benefits of GLP-1s, the class of diabetes and weight-loss drugs known by names like Ozempic, beyond what they were initially approved to treat.

Scientists have discovered a naturally occurring molecule that aids appetite control and weight loss so well, it may compete with popular GLP-1 agonists like Ozempic. It's called BRP (BRINP2-related ...

Mary Ann Schaub, 91, passed away due to natural causes at Peace Hospice on Tuesday, March 4, 2025. Funeral services will be at 11:00 a.m. on Saturday, March 15, 2025, at St. Paul Lutheran Church with ...

A collective winner mentality (Most recent example, the PSG-Liverpool game, see SAF’s + Mourinho’s underperforming teams nicking it) Someone in the Mailbox equated Arteta to Brendan Rodgers ...

Novo Nordisk is rolling out a new national marketing campaign for its GLP-1 juggernaut, teaming up with celebrities and other patients to show what life looks like in their “Ozempic Eras.” ...

Ozempic, a medication for type 2 diabetes and weight loss, mimics the action of GLP-1 to regulate blood sugar and appetite. Although Ozempic itself isn't found in food, high-fiber and probiotic ...

This is despite a current shortage of Ozempic (which is supposed to be prescribed only for people with type 2 diabetes), competition from US rival Eli Lilly and the cost, which means only ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all these options stack up. Are there benefits to one over the other?